Category:
Prophylactic Biological Products
A fixed-dose combination of Gliclazide (CAS 21829-60-3) and Metformin (CAS 1115-70-4) for type 2 diabetes. Synthesized via condensation and salt formation, the molecular formula is C15H21N3O5S·C4H11NO.
Contraindicated in renal impairment; store below 25°C in dry conditions. Monitor lactic acidosis risks during manufacturing and dispensing.